Scientists explored the possible association between the presence of c-MYC, GATA3, and a high level of Ki-67 expression in PTCL patients to confirm whether the GATA3-positive subgroup of tumours is enriched in MYC and proliferative gene signatures compared with other groups. The gene discussed is MYC; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.